Add BrightSurf on Google Email

New study reveals that exposure to a group of widely used ‘forever chemicals’ may increase diabetes risk in middle-aged women

A new study published in Diabetologia found that exposure to per- and polyfluoroalkyl substances (PFAS) is associated with an increased risk of developing diabetes in midlife women. The study analyzed the stored blood and urine samples from 1400 participants and found a stronger association with combined exposure to multiple PFAS.

SourceDiabetologia·JournalDiabetologia·DateApr 11, 2022

GE research-led team treats diabetes using ultrasound

A GE Research-led team has demonstrated the ability to prevent or reverse diabetes in preclinical model systems using ultrasound-based bioelectronic medicine. The team's findings, published in Nature Biomedical Engineering, represent a significant milestone in this field and pave the way for future clinical translation.

SourceGeneral Electric (United States)·JournalNature Biomedical Engineering·TypeRandomized controlled/clinical trial·DateMar 31, 2022

Disparities in diabetic eye care

A new University of Houston study finds racial and ethnic disparities in diabetic eye care, with Whites more likely to receive regular exams than minorities. The study also reveals that Hispanics have the highest prevalence of diabetic eye complications.

SourceUniversity of Houston·JournalDiabetes Epidemiology and Management·DateMar 30, 2022

Is diabetes being overtreated in nursing home residents?

A study found that many nursing home residents continue to receive insulin and other medications despite blood test results suggesting tight control. Only 27% of overtreated and 19% of potentially overtreated residents had their medications adjusted within 2 weeks.

SourceWiley·JournalJournal of the American Geriatrics Society·DateMar 23, 2022

Appetite genes control how children grow

Researchers at the University of Bergen found that genes linked to extreme obesity, appetite, and energy consumption regulate child growth. The study, published in Nature Metabolism, provides insight into mechanisms controlling appetite and energy metabolism early in life, potentially leading to better treatment for obesity.

SourceThe University of Bergen·JournalNature Metabolism·DateMar 21, 2022

Excess sugar consumption costs Canada’s health-care system $5 billion each year

A new study by University of Alberta researchers estimates that excessive sugar consumption in Canada results in $5 billion annual healthcare costs due to 16 chronic diseases. Limiting free sugar intake could reduce diabetes prevalence by 27% if Canadians follow the 10% recommendation, and 44.8% if they limit consumption to less than 5...

SourceUniversity of Alberta·JournalCanadian Journal of Public Health·DateMar 15, 2022

MDI Biological Laboratory scientist identifies mechanism underlying ‘inflammaging’

Researchers at MDI Biological Laboratory discovered that age-related chronic inflammation is caused by disruption of chromatin architecture. This leads to misexpression of genes lacking CpG islands, resulting in inflammation and loss of cellular function. The findings provide a unifying theory for the age-related degenerative diseases.

SourceMDI Biological Laboratory·JournalScience Advances·TypeData/statistical analysis·DateFeb 22, 2022

First get your heart in shape then get pregnant

A new Northwestern Medicine study reveals that more than half of young women in the US have at least one risk factor for poor heart health before pregnancy. Optimizing heart health before and during pregnancy can prevent complications, deliver a healthy baby, and even reduce the risk of heart disease years later.

SourceNorthwestern University·JournalCirculation·DateFeb 14, 2022

New research finds pregnant people with gestational diabetes at increased risk of a wider range of cardiovascular problems than previously thought

A new study finds that women with a history of gestational diabetes are at greater risk for a range of cardiovascular conditions, including coronary artery disease and heart failure. The research, which analyzed data from 219,330 women, suggests that preventative measures during pregnancy may help prevent cardiovascular disease later i...

The diabetes medication that could revolutionise heart failure treatment

A new meta-analysis published in the European Journal of Preventive Cardiology suggests that Sodium-glucose co-transporter-2 (SGLT2) inhibitors can improve outcomes for heart failure patients with preserved ejection fraction. The medication has been shown to reduce the risk of death from heart-related causes and hospitalization by 22%.

SourceUniversity of East Anglia·JournalEuropean Journal of Preventive Cardiology·TypeMeta-analysis·DateNov 30, 2021